ASTH - Company ID 0001083446
The table below shows Astrana Health, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Revenue | $972.52M | $965.10M | $956.05M | $654.81M | $620.39M | $478.71M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
Astrana Health, Inc. reported annual revenue of $3.18B for fiscal year 2025. That is up 56.4% from $2.03B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $57.43M (FY 2017) to $3.18B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $54.15M |
| $61.74M |
| $62.39M |
| $50.73M |
| $43.90M |
| $37.80M |
| Operating income | $34.32M | $28.53M | $19.21M | $20.34M | $20.58M | $28.43M |
| Income tax | $8.76M | $6.58M | $4.59M | $6.61M | $3.38M | $7.83M |
| Net income | $19.74M | $14.44M | $373.00K | $9.42M | $6.69M | $16.09M |
| EPS (diluted) | $0.40 | $0.29 | $0.01 | $0.19 | $0.14 | $0.33 |